Zadikoff C, Munhoz R P, Asante A N, Politzer N, Wennberg R, Carlen P, Lang A
Division of Neurology, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.
J Neurol Neurosurg Psychiatry. 2007 Feb;78(2):147-51. doi: 10.1136/jnnp.2006.100222. Epub 2006 Sep 29.
A wide variety of movement disorders may occur as a consequence of the administration of antiepileptic drugs (AEDs). Although it has been suggested that the risk of parkinsonism is 10-fold higher in those taking valproate as compared with other AEDs, there have been no large, systematic trials assessing this.
To establish more precisely the prevalence of and risk factors for developing parkinsonism associated with valproate use,and to assess the occurrence of movement disorders with the newer AEDs.
Patients with epilepsy were recruited from the Toronto Western Hospital Epilepsy Clinic (University of Toronto, Toronto, Ontario, Canada). Each patient was examined by a movement disorder specialist who was blinded to the treatment status of the patient.
201 patients were included. Postural tremor was the most common movement disorder (45%), followed by parkinsonism (4.5%). The odds of having parkinsonism were 5 times higher with valproate than with other AEDs. No single factor predicted the presence of parkinsonism; however, many (5/9) of the patients concurrently used other drugs or had comorbidities that could have caused or exacerbated parkinsonism. None of the newer AEDs were clearly associated with the presence of movement disorders; however, the numbers were too small to make a formal analysis.
Although the risk of parkinsonism with valproate is higher than with other AEDs, it is lower than originally reported. The cases available were not enough to accurately comment on the prevalence of movement disorders with the newer AEDs.
抗癫痫药物(AEDs)的使用可能导致多种运动障碍。尽管有人提出,服用丙戊酸盐的患者患帕金森症的风险比服用其他抗癫痫药物的患者高10倍,但尚未有大型系统性试验对此进行评估。
更精确地确定与丙戊酸盐使用相关的帕金森症的患病率及危险因素,并评估新型抗癫痫药物引发运动障碍的情况。
从多伦多西部医院癫痫诊所(加拿大多伦多大学,安大略省多伦多)招募癫痫患者。每位患者均由一名对其治疗状况不知情的运动障碍专家进行检查。
共纳入201例患者。姿势性震颤是最常见的运动障碍(45%),其次是帕金森症(4.5%)。服用丙戊酸盐的患者患帕金森症的几率是服用其他抗癫痫药物患者的5倍。没有单一因素可预测帕金森症的存在;然而,许多(5/9)患者同时使用了其他药物或患有可能导致或加重帕金森症的合并症。没有一种新型抗癫痫药物与运动障碍的存在有明确关联;然而,样本数量太少,无法进行正式分析。
尽管丙戊酸盐导致帕金森症的风险高于其他抗癫痫药物,但其风险低于最初报道。现有的病例不足以准确评价新型抗癫痫药物引发运动障碍的患病率。